482169974	482169974	CD	B-NP	O
|	|	HYPH	I-NP	O
V	V	CD	I-NP	O
|	|	HYPH	I-NP	O
63322479	63322479	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7680540	7680540	CD	B-NP	O
|	|	CC	I-NP	O
9/23/2006	9/23/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
cad	cad	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/1/2006	4/1/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/13/2006	9/13/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
CAPLAN	CAPLAN	NNP	B-NP	O
,	,	,	O	O
JARRETT	JARRETT	NNP	B-NP	O
199-82-77-6	199-82-77-6	CD	I-NP	O
Lau	Lau	NNP	I-NP	O
Room	Room	NNP	I-NP	O
:	:	:	O	O
79G-200	79G-200	NNP	B-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
2/26/06	2/26/06	CD	B-NP	O
AT	AT	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
PARADISE	PARADISE	NNP	B-NP	O
,	,	,	O	O
JARROD	JARROD	NNP	B-NP	O
ERICH	ERICH	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
DIGOXIN	DIGOXIN	NN	B-NP	O
0.25	0.25	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
EVERY	EVERY	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DAY	DAY	NNP	I-NP	O
GLYBURIDE	GLYBURIDE	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
ISORDIL	ISORDIL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
DINITRATE	DINITRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
DILANTIN	DILANTIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PHENYTOIN	PHENYTOIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
;	;	:	O	O
250	250	CD	B-NP	O
MG	MG	NN	I-NP	O
QPM	QPM	NN	I-NP	O
PO	PO	NN	I-NP	O
BEDTIME	BEDTIME	NN	I-NP	O
200	200	CD	I-NP	O
MG	MG	NN	I-NP	O
QAM	QAM	NN	I-NP	O
250	250	CD	I-NP	O
MG	MG	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
3/23	3/23	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
also	also	RB	B-ADVP	O
take	take	VBP	B-VP	O
200mg	200mg	CD	B-NP	O
every	every	DT	B-NP	O
afternoon	afternoon	NN	I-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NNP	B-NP	O
TOPROL	TOPROL	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
NEURONTIN	NEURONTIN	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
GABAPENTIN	GABAPENTIN	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
300	300	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
TID	TID	NN	I-NP	I-protein
PLAVIX	PLAVIX	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	O	I-protein
75	75	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
BENAZEPRIL	BENAZEPRIL	NNP	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
DAILY	DAILY	NN	I-NP	I-protein
GLUCOPHAGE	GLUCOPHAGE	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
METFORMIN	METFORMIN	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
850	850	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
resume	resume	VB	B-VP	O
tomorrow	tomorrow	NN	B-NP	O
11/14/06	11/14/06	CD	I-NP	O
CELONTIN	CELONTIN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METHSUXIMIDE	METHSUXIMIDE	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
300	300	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
heavy	heavy	JJ	I-NP	O
lifting	lifting	NN	I-NP	O
for	for	IN	B-PP	O
3-4	3-4	CD	B-NP	O
days	day	NNS	I-NP	O
FOLLOW	FOLLOW	NNP	B-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Nehring	Nehring	NNP	I-NP	O
call	call	NN	I-NP	O
for	for	IN	B-PP	O
appointment	appointment	NN	B-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
cad	cad	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
cad	cad	VBD	B-VP	O
OTHER	OTHER	NNP	B-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
dm	dm	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
dyslipidemia	dyslipidemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
dyslipidemia	dyslipidemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
htn	htn	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
cad	cad	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
chf	chf	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
cabg	cabg	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
cardiac	cardiac	JJ	B-ADJP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
surgery	surgery	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
seizure	seizure	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
seizure	seizure	NN	I-NP	O
disorder	disorder	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
s/p	s/p	NN	I-NP	O
cath	cath	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
ID/CC	ID/CC	NN	B-NP	O
:	:	:	O	O
63M	63M	NN	B-NP	O
transferred	transfer	VBN	B-VP	O
from	from	IN	B-PP	O
LMC	LMC	NN	B-NP	B-protein
with	with	IN	B-PP	O
positive	positive	JJ	B-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
.	.	.	O	O

HPI	HPI	NNP	B-NP	O
Pateint	Pateint	NNP	I-NP	O
has	have	VBZ	B-VP	O
h/o	h/o	NN	B-NP	B-protein
CABG	CABG	NN	I-NP	I-protein
LIMA-D1	LIMA-D1	NN	I-NP	I-protein
,	,	,	O	O
V-OM1	V-OM1	NN	B-NP	B-protein
,	,	,	O	O
V-OM2	V-OM2	NN	B-NP	B-protein
,	,	,	O	O
V	V	NN	B-NP	O
Y-graft	Y-graft	NN	I-NP	O
to	to	TO	B-PP	O
PDA	PDA	NN	B-NP	B-protein
and	and	CC	I-NP	O
PLV	PLV	NN	I-NP	B-protein
.	.	.	O	O

Presented	Present	VBN	B-VP	O
to	to	TO	B-PP	O
FAH	FAH	NN	B-NP	B-protein
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
with	with	IN	B-PP	O
exertional	exertional	JJ	B-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

ROMI	ROMI	NN	B-NP	O
.	.	.	O	O

Nuclear	Nuclear	JJ	B-NP	O
stress	stress	NN	I-NP	O
reveled	revel	VBD	B-VP	O
inferior	inferior	JJ	B-NP	O
scar	scar	NN	I-NP	O
and	and	CC	O	O
small	small	JJ	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
anterior	anterior	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

Transferred	Transfer	VBN	B-VP	O
to	to	TO	B-PP	O
CTMC	CTMC	NN	B-NP	B-protein
for	for	IN	B-PP	O
cath	cath	NN	B-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
Seizure	Seizure	NN	I-NP	O
d/o	d/o	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
CABG	CABG	NN	B-NP	B-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	O
COPD	COPD	NN	I-NP	O
,	,	,	O	O
Schizo-affecitve	Schizo-affecitve	NNP	B-NP	O
disorder	disorder	NN	I-NP	O
,	,	,	O	O
dyslipidemia	dyslipidemia	NN	B-NP	O
Meds	Med	NNS	I-NP	O
on	on	IN	B-PP	O
transfer	transfer	NN	B-NP	O
:	:	:	O	O
Dilantin300/300/250	Dilantin300/300/250	NN	B-NP	O
,	,	,	O	O
glyburide	glyburide	NN	B-NP	O
10	10	CD	I-NP	O
BID	BID	NN	I-NP	O
,	,	,	O	O
metformin	metformin	NN	B-NP	O
850	850	CD	I-NP	O
tid	tid	NN	I-NP	O
,	,	,	O	O
toprol	toprol	NN	B-NP	O
100	100	CD	I-NP	O
Daily	Daily	NNP	I-NP	O
,	,	,	O	O
ASA	ASA	NNP	B-NP	O
325	325	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
isordil	isordil	NN	B-NP	O
20tid	20tid	CD	I-NP	O
,	,	,	O	O
lasix	lasix	CD	B-NP	O
20	20	CD	I-NP	O
QOD	QOD	NN	I-NP	O
,	,	,	O	O
lipitor	lipitor	NN	B-NP	O
40	40	CD	I-NP	O
Daily	Daily	NNP	I-NP	O
,	,	,	O	O
neurontin	neurontin	NN	B-NP	B-protein
,	,	,	O	O
celondin	celondin	NN	B-NP	O
300	300	CD	I-NP	O
TID	TID	NN	I-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.25	0.25	CD	I-NP	O
Daily	Daily	NNP	I-NP	O
,	,	,	O	O
benazepril	benazepril	NN	B-NP	O
10	10	CD	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Allergies	Allergy	NNS	B-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
SH	SH	NN	I-NP	O
:	:	:	O	O
lives	life	NNS	B-NP	O
alone	alone	RB	B-ADVP	O
****	****	SYM	O	O
Hospital	Hospital	NNP	B-NP	O
Course	Course	NNP	I-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
Cath	Cath	NN	B-NP	O
LIMA-LAD	LIMA-LAD	NN	I-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

SVG	SVG	NN	B-NP	O
Y	Y	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
PDA	PDA	NN	B-NP	B-protein
and	and	CC	I-NP	O
LV	LV	NN	I-NP	O
mid	mid	NN	I-NP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
graft	graft	NN	B-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

SVG	SVG	NN	B-NP	O
to	to	TO	B-PP	O
both	both	CC	O	O
OM	OM	NN	B-NP	O
branches	branch	NNS	I-NP	O
occluded	occlude	VBD	B-VP	O
.	.	.	O	O

RCA	RCA	NN	B-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
LAD	LAD	NN	B-NP	O
mid	mid	VBD	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
LCx	LCx	NN	B-NP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
ASA	ASA	NN	B-ADJP	O
resistant	resistant	JJ	I-ADJP	O
will	will	MD	B-VP	O
change	change	VB	I-VP	O
to	to	TO	B-PP	O
plavix	plavix	NN	B-NP	O
75	75	CD	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
meds	med	NNS	I-NP	O
:	:	:	O	O
Toprol	Toprol	NN	B-NP	O
100	100	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
isordil	isordil	NN	B-NP	O
20	20	CD	I-NP	O
tid	tid	NN	I-NP	O
Lasix	Lasix	NN	I-NP	O
20	20	CD	I-NP	O
QOD	QOD	NN	I-NP	O
.	.	.	O	O

atorva	atorva	NN	B-NP	O
switched	switch	VBD	B-VP	O
to	to	TO	B-PP	O
simva	simva	NN	B-NP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
,	,	,	O	O
benazepril	benazepril	NN	B-NP	O
to	to	TO	B-PP	O
lisinopril	lisinopril	NN	B-NP	O
10	10	CD	I-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.25	0.25	CD	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

DM	DM	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
hold	hold	VB	I-VP	O
metformin	metformin	NN	B-NP	O
,	,	,	O	O
restart	restart	VB	B-VP	O
glyburide	glyburide	NN	B-NP	O
and	and	CC	O	O
start	start	VB	B-VP	O
RISS	RISS	NN	B-NP	B-protein
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Staying	Stay	VBG	B-VP	O
overnight	overnight	RB	B-ADVP	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
lives	live	VBZ	B-VP	O
alone	alone	RB	B-ADVP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
way	way	NN	I-NP	O
of	of	IN	B-PP	O
getting	get	VBG	B-VP	O
home	home	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Neuro	Neuro	NNP	B-NP	O
:	:	:	O	O
Cont	Cont	NNP	B-NP	O
neurontin	neurontin	NN	I-NP	O
300	300	CD	I-NP	O
TID	TID	NN	I-NP	O
,	,	,	O	O
dilantin	dilantin	NN	B-NP	O
200/200/250	200/200/250	CD	I-NP	O
,	,	,	O	O
celondin	celondin	NN	B-NP	O
-	-	HYPH	B-NP	O
listed	list	VBN	B-VP	O
on	on	IN	B-PP	O
meds	med	NNS	B-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	B-PP	O
but	but	CC	I-PP	O
not	not	RB	B-PP	O
on	on	IN	I-PP	O
home	home	NN	B-NP	O
meds	med	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
if	if	IN	B-SBAR	O
he	he	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
or	or	CC	O	O
not	not	RB	O	O
.	.	.	O	O

11/20/06	11/20/06	CD	B-NP	O
pt	pt	NN	I-NP	O
stable	stable	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
ready	ready	JJ	I-ADJP	O
for	for	IN	B-PP	O
d/c	d/c	NN	B-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
take	take	VB	B-VP	O
all	all	DT	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
prescribed	prescribe	VBN	B-VP	O
.	.	.	O	O

Call	Call	VB	B-NP	O
with	with	IN	B-PP	O
any	any	DT	B-NP	O
questions	question	NNS	I-NP	O
or	or	CC	I-NP	O
concerns	concern	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
BEHM	BEHM	NNP	B-NP	O
,	,	,	O	O
CRISTOBAL	CRISTOBAL	NNP	B-NP	O
,	,	,	O	O
PA	PA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DG70	DG70	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2/26/06	2/26/06	CD	I-NP	O
@	@	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
50	50	CD	B-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

